146 related articles for article (PubMed ID: 29874469)
1. MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7.
Niu JT; Zhang LJ; Huang YW; Li C; Jiang N; Niu YJ
Biochem Cell Biol; 2018 Dec; 96(6):752-760. PubMed ID: 29874469
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA‑34a/c function as tumor suppressors in Hep‑2 laryngeal carcinoma cells and may reduce GALNT7 expression.
Li W; Ma H; Sun J
Mol Med Rep; 2014 Apr; 9(4):1293-8. PubMed ID: 24482044
[TBL] [Abstract][Full Text] [Related]
3. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
Zheng Y; Duan L; Yang Y; Luo D; Yan B
Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
[TBL] [Abstract][Full Text] [Related]
4. miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma.
Zhao X; Zhang W; Ji W
Future Oncol; 2018 Jul; 14(17):1741-1753. PubMed ID: 29517349
[TBL] [Abstract][Full Text] [Related]
5. [Study on the mechanism of miR-497-induced laryngeal squamous cell carcinoma growth inhibition by targeting CDK6].
Niu JT; Liu SG; Yan P; Li C
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 54(2):126-132. PubMed ID: 30776865
[No Abstract] [Full Text] [Related]
6. miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.
Lu Q; Xu L; Li C; Yuan Y; Huang S; Chen H
Tumour Biol; 2016 Nov; 37(11):14605-14614. PubMed ID: 27619677
[TBL] [Abstract][Full Text] [Related]
7. Lack of miR-1246 in small extracellular vesicle blunts tumorigenesis of laryngeal carcinoma cells by regulating Cyclin G2.
Huang Q; Hsueh CY; Guo Y; Wu XF; Li JY; Zhou L
IUBMB Life; 2020 Jul; 72(7):1491-1503. PubMed ID: 32196930
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑195 inhibits cell proliferation, migration and invasion in laryngeal squamous cell carcinoma by targeting ROCK1.
Liu Y; Liu J; Wang L; Yang X; Liu X
Mol Med Rep; 2017 Nov; 16(5):7154-7162. PubMed ID: 28901478
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.
Zhao XD; Zhang W; Liang HJ; Ji WY
PLoS One; 2013; 8(2):e56395. PubMed ID: 23437123
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.
Zheng X; Zhao K; Liu T; Liu L; Zhou C; Xu M
J Cell Biochem; 2019 Mar; 120(3):3911-3921. PubMed ID: 30304557
[TBL] [Abstract][Full Text] [Related]
11. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA ABCB10 contributes to laryngeal squamous cell carcinoma (LSCC) progression by modulating the miR-588/CXCR4 axis.
Zhao J; Li XD; Wang M; Song LN; Zhao MJ
Aging (Albany NY); 2021 May; 13(10):14078-14087. PubMed ID: 34015764
[TBL] [Abstract][Full Text] [Related]
14. miR-506 is a YAP1-dependent tumor suppressor in laryngeal squamous cell carcinoma.
Gao C; Hu S
Cancer Biol Ther; 2019; 20(6):826-836. PubMed ID: 30907227
[TBL] [Abstract][Full Text] [Related]
15. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-625 inhibits cell invasion and epithelial-mesenchymal transition by targeting SOX4 in laryngeal squamous cell carcinoma.
Li Y; Tao C; Dai L; Cui C; Chen C; Wu H; Wei Q; Zhou X
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30563928
[TBL] [Abstract][Full Text] [Related]
17. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
[TBL] [Abstract][Full Text] [Related]
18. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.
Wang Z; Huang C; Zhang A; Lu C; Liu L
Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687
[TBL] [Abstract][Full Text] [Related]
20. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC).
Yungang W; Xiaoyu L; Pang T; Wenming L; Pan X
Biomed Pharmacother; 2014 Mar; 68(2):149-54. PubMed ID: 24055400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
